Tokushima, Japan

Koichi Nishida


Average Co-Inventor Count = 9.5

ph-index = 2

Forward Citations = 54(Granted Patents)


Location History:

  • Tokushima, JP (1999)
  • Itano-gun, JP (1999)

Company Filing History:


Years Active: 1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Antibiotic Resistance: The Work of Koichi Nishida

Introduction

Koichi Nishida, located in Tokushima, Japan, is a prominent inventor known for his contributions in the field of medicinal chemistry, particularly in the development of compounds that combat antibiotic resistance. With a focus on .beta.-lactamase inhibitors, Nishida holds two patents that highlight his innovative approach to enhancing the efficacy of existing antibiotics.

Latest Patents

Nishida's latest patents include significant advancements in the formation of azetidinone derivatives as .beta.-lactamase inhibitors. The first patent describes new 2-oxo-1-azetidine sulfonic acid derivatives featuring an aminoalkyl substituted 'anti' (E-isomer) oxyimino group at the 3 position of the monobactam ring. These compounds have been found to be potent inhibitors of bacterial .beta.-lactamases, making them essential in conjunction with .beta.-lactam antibiotics to boost their effectiveness against infections caused by bacteria that produce .beta.-lactamase. The second patent focuses on a compound of formula (I), wherein R1 is selected from various groups, such as 2-thienyl, 2-furyl, 2-pyrrolyl, 1-methyl-2-pyrrolyl, 2-amino-1-thiazolyl, and 5-isothiazolyl, demonstrating a strong potential as a .beta.-lactamase inhibitor.

Career Highlights

Throughout his career, Koichi Nishida has worked with reputable companies in the pharmaceutical industry, including Synphar Laboratories, Inc. and Taiho Pharmaceutical Company Limited. His experience at these institutions has allowed him to further his research and development efforts in pharmaceutical innovation.

Collaborations

Nishida has collaborated with notable coworkers, including Samarendra N. Maiti and Oludotun A. Phillips. These partnerships have led to significant findings in the realm of beta-lactamase inhibition and have contributed to advancing the collective understanding of antibiotic resistance.

Conclusion

Koichi Nishida's contributions to the field of antibiotic resistance through his innovative compounds demonstrate the vital role inventors play in addressing pressing health challenges. His patents reflect a commitment to enhancing the effectiveness of antibiotics, showcasing the potential of collaborative efforts in research and the importance of continuous innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…